Targeted Nanoparticles and Specific Cell Targeting Strategies for Chronic Liver Disease
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (31 October 2022) | Viewed by 3038
Special Issue Editor
Interests: alcoholic liver injury; non-alcoholic fatty liver; steatohepatitis; nanoparticle; fibrosis; Kupffer cell; macorphage; senescence; muscle regeneration; cancer; diagnostic marker
Special Issue Information
Dear Colleagues,
Various nanoparticles have recently emerged and been widely applied in drug delivery, nanomedicine, advanced diagnostic imaging fields, and cancer therapy. Nanoparticles have several merits in terms of cell-specific targeting due to their applicable nanoscale sizes. The liver is one of the most important immune organs encountering several exogenous materials entering the human body system, which means that it is also one of main target organs for nanoparticle application for treatment or diagnosis. Cell-specific targeting through nanoparticle modification is a promising strategy to treat chronic liver disease, and various target cells can be effective depending on the liver disease stage. Therefore, cell-specific targeting strategies such as liver Kupffer cells, neutrophils, sinusoidal vessel endothelial cells, hepatic stellate cells, and hepatocytes are essential to modulate various therapeutic targets in chronic liver disease as well as in liver cancer. This Special Issue welcomes any original research and reviews related to various cell specific targeting strategies, modifications, characterizations of novel nanoparticles to target various liver cells as well as modulation of various therapeutic targets using nanoparticle-based delivery systems for chronic liver disease and liver cancer.
Dr. Jin-Kyu Park
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomedicine
- nanoparticle-based gene delivery
- nanoparticle-based drug delivery
- cell-targeted nanoparticle
- nanoparticle modification
- chronic liver disease
- Kupffer cell
- liver cell
- cell-specific targeting
